Categories - Tuesday 8:30 AM – 11: 00 AM
| Administrative Practice / Financial Management / Human Resources, Ambulatory Care, Automation/Informatics, Cardiology, Chronic Care/Managed Care, Clinical Services Mangement, Critical Care, Emergency Preparedness, Geriatrics, Herbels Alternative Medicines, Home Care, I.V. Therapy Infusion, Infectious Diseases, Nutrition Support, Pain Mangement, Psychopharmacy/Neurology, Quality Assurance / Medication-Use Safety |
Administrative Practice / Financial Management / Human Resources
Board 1 Comparison of implementation of open architecture clean rooms at two large academic medical centers, Angela W. Yaniv, Stephen D. Arrowood, Gregory Wright, Michael Canale, David A. Kvancz (P1D)
Board 2 Comprehensive pharmacy professional development program at Intermountain Medical Center, Nannette M. Berensen, Bruce E. Leavitt (2D)
Board 3 Decreasing pharmacy spend through the optimization of group purchasing organization contracts an alternative care site, Todd Karpinski, Traci Metting (P3D)
Board 4 Developing a pharmacy executive scorecard: a method for conveying pharmacy performance, Gregory Doerr, Sheree Foster, Erin Hendrick (P4D)
Board 5 Developing teaching skills for pharmacists to provide public educational programs on rational drug usage in Taiwan, Camia SH Shen, Chiung Sheue Chen, Rong Chi Yang (P5D)
Board 6 Development and evaluation of an anticoagulation therapy training manual for hospital pharmacists, Nathan B. Lamb, John Farringer (P6D)
Board 7 Employee recognition programs in the department of pharmacy services at Intermountain Medical Center, Nannette M. Berensen, Bruce E. Leavitt (P7D)
Board 8 Environmental compromises in an open architecture clean room, Angela W. Yaniv, David A. Kvancz (P8D)
Board 9 Hospital-wide analysis of preprinted medication order sets at a tertiary community hospital, Jennifer L. Jebrock, Antonia Zapantis, Robert J. Kraljevich (P9D)
Board 10 Implementation of a kanban system to improve inventory management and availability of pharmaceuticals, Winson Soo-Hoo, Lynne Goldstein, Greg Bauer, Walter Proch, Saeeda King (P10D)
Board 11 Implementation of a shared governance model in pharmacy practice, J. G. Barbaccia, Wendy Perry, Kimberly Krakowski (P11D)
Board 12 Improving labor efficiencies through monitoring automated dispensing cabinet benchmarks, James R. Maddock, Marla G. Madsen, W. Perry Flowers (P12D)
Board 13 Maximizing shelf life of medications: an approach to drug cost containment, Cynthia Jeter, Erin Hendrick (P13D)
Board 15 Medication use process in a Middle East country: results of the first national pharmacist opinion survey in Qatar, Maguy S. El Hajj, Manal B. Al-Zaidan, Nadir Kheir, Peter Jewesson (P15E)
Board 16 Professional satisfaction in a Middle East country: pharmacist opinions in Qatar, Maguy S. El Hajj, Manal B. Al-Zaidan, Nadir Kheir, Peter Jewesson (P16D)
Board 17 Success of a formalized decision making process to guide the decisions and implementation of pharmacy initiatives in large nonprofit health system, Annette M. Karageanes, Larry J. Koesterer, Diane K. Mends (P17D)
Ambulatory Care
Board 18 A prospective cohort study comparing the efficacy and tolerability of varenicline in heavy vs. light smokers, Laura L. Bowers, Steve Fuller, Bob Cisneros, Scott Holuby, Kim Lewis (P18E)
Board 19 Development of the Boston ambulatory care clinical pharmacist network, Laura A. Bogdanski, David M. Schnee, Jennifer D. Goldman-Levine (P19D)
Board 20 Effect of transdermal alcohol on international normalized ratio (INR): a case series of 3 warfarin treated patients, Margaret Pitcock, James J. Pitcock (P20D)
Board 21 Ethnicity/race, use of pharmacotherapy, and rate of physician ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during U.S. office-based visits by patients with hyperlipidemia, Megan Willson, David Alexander Sclar, Cristina Duvall, Linda Robison, Tracy Skaer (P21D)
Board 22 Evaluation of appropriate monitoring for atypical antipsychotic medications in the VA population, Colleen Cook Tobia, Rebecca Roman (P22D)
Board 23 Evaluation of medication conversions following a statin formulary change, Summer Peregrin, Sharry Veres, Greg Morrill (P23E)
Board 24 Framework for understanding quality in the community pharmacy setting, Devina Halsall, Peter Noyce, Darren Ashcroft (P24E)
Board 26 Impact of a pharmacist's collaborative management, adherence, and medication education program (CAMP) in an ambulatory renal clinic, Jenin Lee, Nelson Chee, Audrey Lee, Phillip Chiao, Kirsten Johansen (P26E)
Board 27 Impact of the "medical home" on the safety and quality of health care in Canada, Neil J. MacKinnon, Andrea Scobie, Sean Higgins, Holly Etchegary, Robin Osborn (P27D)
Board 28 Implementation of a collaborative drug therapy management protocol for warfarin interruptions in a large centralized anticoagulation service, Heidi L. Chinwuba, Diane Ditmer, Andrew Felcher, Thomas Wright, Michael Nash (P28D)
Board 29 Integration and impact of a medication therapy management service at an ambulatory medical practice, Tanya Najarian, Elizabeth Boucher, Amy Vachon, Seth Robin, Marianne Lee (P29D)
Board 30 Outcomes of a lipid group clinic on achieving targeted low-density lipoprotein cholesterol (LDL-C) goals in a veteran population, S. Rochelle Moore, Karen Korch Black (P30D)
Board 31 Pharmacist evaluation of non-HDL cholesterol in diabetic patients at goal for LDL cholesterol and the potential use of fish oil, Stephanie Lobosco, Kathy Zaiken (P31D)
Board 32 Pharmacist managed cardiovascular risk reduction clinic: an intervention versus standard care comparison of outcomes in achieving hypertension goals, Jessica Wellman, Crystal Wink, Beth Bryant (P32E)
Board 33 Treatment of monotherapy with lopinavir/ritonavir, Genma Riadigos Silva, Nuria Rudi, Anisi Moron, Manel Cervantes, Miquel Cruel (P33D)
Board 34 Two case reports of falsely lowered A1C readings secondary to chronic anemia, David M. Schnee, Jennifer Goldman-Levine (P34E)
Board 35 Warfarin resistance in a patient with hyperparathyroidism, Julie Stading, Alan Chock, Veronica West (P35D)
Automation/Informatics
Board 36 Employment of bar code technology in the dispensation of compound preparations for outpatients, Estibaliz Chavarri, Beatriz Sordo, Monike De Miguel, Maria Angeles Gil, Beatriz Baza (P36D)
Board 37 Impact of computerized prescriber order entry on medication turn-around time, Karen E. Trenkler, Mark Franklin, Thomas Wheeler, Kathleen Joyce (P37E)
Board 38 Improving inpatient pharmacy operating efficiencies through automated dispensing implementation, Beth A. Carberry, Seth A. Kuiper (P38D)
Board 39 Improving patient care through electronic admission medication reconciliation, Kim Tran, Marcelle Levy-Santoro, George Kreytak, Bella Kohn, Richard Perry (P39D)
Board 40 Just in time delivery of pharmaceuticals: improved stock-out rates, Peter Le, Marla Madsen, W. Perry Flowers (P40D)
Board 41 Medication error analysis associated with the implementation of a computerized physician order entry (CPOE) system, Cheryl Krempa, Susan Gugliotta, (P41D)
Board 42 Readability of professional and consumer-targeted herbal monographs used for diabetes and chronic fatigue syndrome, Kevin A. Clauson, Qing Zeng-Treitler, Sasikiran Kandula (P42D)
Board 43 The impact of lecture podcast availability on student examination scores, Margarita V. DiVall, Mark Douglass, J. Andrew Skirvin (P43E)
Board 44 Utilizing information technology for an inpatient pharmacist-managed anticoagulation program, Ewa M. Dzwierzynski, James Smith, Allen McGaughey, Christine Berard-Collins (P44D)
Cardiology
Board 45 Decompensated congestive heart failure: treatment with an ultrafiltration device and anticoagulation methods, Estella M. Davis, Pamela A. Foral, Brenda L. Kreuger, Kelly K. Nystrom, Carla M. Christensen (P45D)
Board 46 Development of a heparin nomogram for patients with end-stage heart failure and mechanical circulatory assist devices, Angela J. Hermosillo, Andrew Peterson, Mary Lou O’'Hara, Rohinton Morris, Sarah Spinler (P46E)
Board 47 Implementation of a multidisciplinary anticoagulation education program for staff, patients and families at a community hospital, Michele Danish, Diana Mercurio, Carolyn Moretti, Karen Dean, Michael Sipala (P47D)
Chronic Care / Managed Care
Board 48 Drugs, pharmaceutical manufacturers and conflicts of interest: pharmacy and therapeutics committee survey, Roy Guharoy, John Noviasky, Christian Hartman, Reetu Gupta (P48D)
Board 49 Evaluation of statin and concomitant ezetimibe therapy, John Grossomanides, Carl Possidente (P49D)
Board 50 Evaluation of the compliance for the combination therapy with oral anti-diabetic agents, Jeeyeon Yun, Ok Youn Han, Seung Yeon Moon (P50E)
Board 51 Pharmacists can make a difference in global health, Aline Saad (P51D)
Board 52 Rapid and enduring relief of nasal congestion: new data on mometasone furoate nasal spray onset of action and duration of efficacy, Dennis M. Williams (P52E)
Clinical Services Management
Board 53 Assessment of a warfarin dosing method in adult inpatients in a community hospital, Ramadas Balasubramanian, Kim D. Mango, Jeffrey D. Andrievk, Martin Emsermann, Carolyn L. Kerr (P53D)
Board 54 Benchmarking leveraging best practice or best performance, Karen Miller, Rabiah Dys, Charlene Hope (P54D)
Board 55 Benchmarking: leveraging best-practice strategies to implement anticoagulant and antibiotic management tools, Karen Miller, Rabiah Dys, Charlene Hope (P55D)
Board 56 Clinical staff models: current practice in academic medical centers, Roy Guharoy, Nora Flint, Mike Fotis, Barbara Faircloth, Steven Baroletti (P56D)
Board 57 Comparison of a nomogram and physician-adjusted dosage of warfarin in hospitalized patients initiating warfarin therapy, Jennifer Locker, Karen E. Trenkler (P57D)
Board 58 Development and results of a pharmacist driven inpatient warfarin service, Jovino O. Hernandez, Karen Siegel, Glenn Wysock, Jeff Beeman (P58D)
Board 59 Development of an advanced pharmacy student internship program at a community hospital, Elizabeth K. Pogge, Estella M. Davis, Phillip J. Vuchetich, Pamela A. Foral, Kelly K. Nystrom (P59D)
Board 60 Evaluating the productivity, demand, and reimbursement of an anticoagulation clinic in a community hospital, Julie E. Kim, Kelly K. Nystrom, Robert T. Meyer, Carla M. Christensen, Estella M. Davis (P60D)
Board 61 Evaluation of antimicrobial stewardship programs and their relationship to pharmaceutical expenditures, Lisa Prather, Charlene A. Hope, Stacy Ramga, Karen Miller, Bea Dys (P61D)
Board 62 Impact of using-age-adjusted creatinine clearance on vancomycin trough levels in patients over sixtyfive years old in a community hospital, Ramadas Balasubramanian, Kim D. Mango, David A. Bilotta, Kara Beth Haynes, Michael C. Rea (P62D)
Board 63 Implementation of a pharmacy renal-dosing protocol in a community hospital, Ramadas Balasubramanian, Kim D. Mango, Donna M. Thompson, David A. Bilotta, Michael C. Rea (P63D)
Board 64 Implementation of nightshift integrated, decentralized clinical pharmacy services in an acute care, teaching hospital, Robert A. Moye (P64D)
Board 65 Need for investigational drug services at a tertiary community hospital, Emily Hoffman, Antonia Zapantis, Ramesh Neerpat, Robert J. Kraljevich (P65E)
Board 66 Optimization of the activity of clinical pharmacy through the analysis of discrepancies of coding for 5500 drug-related problem, Emmanuelle Orru Bravo, Chloe Tesmoingt, Emmanuelle Papy, Beatrice Menneglier, Faouzia Bouziane (P66D)
Board 67 Pharmacist-managed anticoagulation service at a community hospital becomes model for large five-hospital system, Kristen Kusmierski, Cynthia Lackie, Daniel Ryszka, Timothy Reed (P67D)
Board 68 Pharmacist's role in clinical monitoring in the post-operative surgical patient, Michelle Holm, Tadd Hellwig, Jenna Lovely (P68D)
Board 69 Recall 101: organizing a response to a major market withdrawal at a large academic medical center, Cindy Wordell, Precil Varghese, Brian Roslund, Lynda Thomson, Brian Swift (P69D)
Board 70 Suggestion of patient management through analyzing warfarin use before and after ablation, Suhyun Kim, Seongsim Ann (P70D)
Board 71 Using FMEA to design an anticoagulation service, Rosella Hoffmann, Gayle Cotchen, Constance Timko, Christine K. O'Neill, Mary Dyer (P71D)
Critical Care
Board 72 Development and implementation of remote ICU clinical pharmacy services, Christian Hartman, Milka Njoroge, Christopher Schifferdecker, Brian Smith, Craig Lilly (P72D)
Board 74 Effect on sepsis mortality rate at a regional acute care institution after implementation of the Institute of Healthcare Improvement (IHI) sepsis bundles, Marsha F. Crader, Cynthia E. Garris (P74D)
Board 75 Evaluation of the adherance to a ventilator-associated pneumonia order set: appropriate empiric antibiotic choice and de-escalation of therapy, Andrew Moyer, Claudine El-Beyrouty, Carrie McClintic (P75D)
Board 76 Impact of pharmacist and intensivist on stress ulcer and deep venous thrombosis prophylaxis rates in the critically Ill, Deepali Dixit, Robert Adamson, Paul Yodice (P76E)
Board 77 Improving glycemic control among cardiac surgery patients in a community hospital, Jennifer G. Steinberg, Heidi Clarke, Radhan Gopalani (P77E)
Board 78 Improving outcomes in ventilated patients through multi-disciplinary protocol development, Deborah Boles (P78D)
Board 79 Intensive insulin therapy and glycemic control in the medical intensive care unit at a university hospital, Jason Ellison (P79D)
Board 80 Multidisciplinary approach to certifying pharmacy students in advanced cardiac life support, Karen L. Kier, Ronda D. Hunter, John Norris (P80D)
Board 81 Potential impact of the pharmacist's recommendation on a patient care in a coronary care unit, Cristina Perez Sanz, Silvia Manrique, Rodriguez Carmen, Esteva Laura, Sanjurjo María (P81D)
Board 82 Surveillance of heparin-induced thrombocytopenia (HIT) outcomes to facilitate protocol development for the use of direct thrombin inhibitors, Kalliopi Fitousis, Jodi Klocek, Betsy Carlisle, Leticia Smith (P82D)
Emergency Preparedness
Board 83 Emergency preparedness: a model for rapid distribution of vaccines or medications in a health-care network, Michela Catalano, Lucille Ferrara, Keith Veltri, Ellen Rudnick, Nadia Ferguson-Myrthil (P83D)
Board 84 Evolution of a French pharmacy biological, chemical, nuclear and radiologic risk preparedness plan, Annick Terrier, Corrine Feutrier, Chantal Verdier, Alain Nageotte (P84D)
Geriatrics
Board 85 Does cognitive impairment compromise anticoagulation control in elderly patients?, Travis E. Sonnett, Stephen M. Setter, Soo Borson, Douglas L. Weeks, Jennifer Taylor (P85E)
Board 86 Effect of pharmacy interventions on the occurrence of medication-related falls in a community hospital, Chaitra Swain, Radhan Gopalani, Jennifer Steinberg, Gloria Kelly (P86D)
Board 87 Pharmacy monitoring of once daily tobramycin in elderly adults at a 210 bed urban hospital, Kevin McDonough, Diana Finkel, James Vieira (P87D)
Board 88 Retrospective review of the effect of acetylcholinesterase inhibitors (AChEIs) on mini-mental status examination (MMSE), the minimum data set (MDS) cognitive performance scale (CPS) and global MDS assessments over a five year period, Brad Hein, Tara Wheatley, Meenakshi Patel, Norbert Kinross, Jr. (P88D)
Herbals /Alternative Medicines
Board 89 Paucity of safety information in a national sample of St. John's wort product labeling, Kevin A. Clauson, Marile L. Santamarina, Jennifer C. Rutledge (P89D)
Home Care
Board 90 Managing a heparin recall within a national pharmacy that services multiple patient care settings, Lisa Linn Siefert, Steve Kennedy, Nita Meaux, Tom Rout, Donna Ford (P90D)
Board 91 Participation of a home infusion operation in a parenteral fish-oil-based fat emulsion compassionate treatment protocol, Jean Mildenberger, Kathleen McTernan, Penny Allen, Don Filibeck (P91D)
Board 92 Preparing a home infusion operation to participate in a clinical drug trial, Greg Poletaev, Michelle Goebel, Catherine Murphy, Dawn Burman (P92D)
I.V. Therapy / Infusion Devices
Board 93 A multidisciplinary approach to evaluate, develop,and implement a standardized infusion drug library, Palma Berardi, Karen Michaels, Elizabeth Regan (P93D)
Board 94 Benefits of long-term administration of immune globulin intravenous, 10 percent caprylate/chromatography purified (IGIV-C) in neurology: data from a randomized phase 3 trial in chronic inflammatory demyelinating polyneuropathy, Peter Donofrio, Chunqin Deng, Kim Hanna (P94E)
Board 95 Infusion rate and stability of 5-fluorouracil in disposal infusion device, anapa, Jung Tae Kim, Sung Hyun Chung (P95E)
Board 96 Preparation and physicochemical stability of diltiazem 1mg/ml prediluted in normal saline and dextrose 5 percent using an automated compounding system, Salvador Jane, Jordi Menendez, Joan Girbau (P96E)
Board 97 Stability and sterility of alemtuzumab 50 mcg/mL in 0.9% sodium chloride in plastic bags for 28 days at 4 C, Lee Vermeulen, Erik Puffer, Micheal Hallum, Rita Hoke, Jill Kolesar (P97E)
Board 98 Stability of intravenous amiodarone formulations in glass, polyolefin and polyvinylchloride containers over 72 hours, Paul F. Souney, Jane Cowee, Gerold Mosher, Daniel J. Cushing (P98E)
Board 99 Stability of levofloxacin injection premix flexible containers following removal from foil overwrap, Kevin Long, Karen R. Zimm, Alexander P. Danyluk, Judy Wagner (P99E)
Board 100 The physical compatibility of oritavancin diphosphate with selected co-administered drugs during simulated Y-site administration, Henry J. Mann, Atul Kumar (P100E)
Infectious Diseases
Board 101 Acceptance of antimicrobial management team recommendations in a rural community teaching hospital, Brad R. Laible, Jawad Nazir, Aris Assimacopoulos, Jennifer Schut (P101E)
Nutrition Support
Board 102 Pancrelipase delayed-release capsules zero-overfill formulation (to-be-marketed) is pharmaceutically equivalent to the current formulation, George Shlieout, Andreas Koerner, Frithjof Czesny, Bernd Thumbeck, Jens Onken (P102E)
Board 103 Parenteral nutrition in critical care, Albert Planas, César Salort, Noemí Villén, Rosa Garriga, Ramón Pla (P103D)
Board 104 Using electronic refractive index for testing glucose concentration in pediatric parenteral nutrition, Mark W. MacKay, Kevin Jones, Marc Holley, Jared Cash, Brian Winther (P104D)
Pain Management
Board 105 A pharmacy pain management service as part of multi-disiplinary effort to improve patient satisfaction scores in patients undergoing spinal surgery, John J. Engelbert, Angel Li, Jerald Limcolioc, Monique Revasco-Reyes, Christina Valencia (P105D)
Board 106 Evaluation of the use of oral ketamine as adjuvant therapy for patients with severe pain in a tertiary care institution, Stephanie Seyse, Regina Ventura, Anthony Jarkowski, Kristen Kusmierski, Kathy Truong (P106D)
Board 107 Medication use among workers with pain in the United States, Gary Vorsanger, Jim Xiang, John Lococo (P107D)
Board 108 Release of sequestered naltrexone following tampering with ALO-01 (morphine sulfate extended-release with sequestered naltrexone hydrochloride) capsules mitigates morphine-induced euphoria when taken by recreational drug users, James B. Jones, Paul F. Cavanaugh, Jr., Jillmarie Yanchick, Franklin Johnson (P108E)
Psychopharmacy / Neurology
Board 109 Acute bowel necrosis associated with clozapine therapy, Stephen M. Dolley, Anna K. Morin (P109E)
Board 110 The impact of a pharmacy led metabolic syndrome clinic in a state psychiatric hospital, Cam McQueary, Diane Barres, Sarah Kuhn, Thomas Gray, Mark Catalanello (P110D)
Quality Assurance / Medication-Use Safety
Board 111 Accidental venous administration of an oral iron preparation, Maria Puy Figuero, Francisco Javier Gonzalez, Estibaliz Perez, Ainara Campino, Begoña San Jose (P111D)
Board 112 Adding a pharmacy technician to the emergency department: improving medication reconciliation, Alicia ZuWallack, Tiffany Floody, Rany Cover, Brenda Lefort, Patricia Racioppi (P112D)
Board 114 Analysis of nurse verification labels on heparin and insulin infusion bags in an SICU and CICU setting, Marilyn J. Novell, Mary Hatcher (P114D)
Board 115 Can an end tidal carbon dioxide device enable more accurate dosing and monitoring of post surgical patients on patient controlled analgesia?, Michelle An, Elizabeth Beener, Scot Nolan, Renee Smilde, Eung Kim (P115E)
Board 116 CLARi-5: advancement of patient safety using eMAR, pharmacist order entry and bedside scanning, Melanie Flinn, Brian Cohen, Marvin Skinner, Toni Johnson, Michelle Ruhl (P116E)
Board 117 Clinical pharmacy enhances drug safety by initiating production of a triple-solution containing ropivacaine, ketorolac and epinephrine, Birthe Soenniksen, Josef Nejatbakhsh, Birgitte Madsen, Helle Jespersen (P117D)
Board 118 Development of a medication safety and quality scorecard at a large academic medical center, Christian Hartman, Hanh Chu, Roy Guharoy (P118D)
Board 119 Effect of a clinical pharmacist on compliance with the Centers for Medicare and Medicaid Services (CMS) quality measures for acute myocardial infarction (AMI) and heart failure (HF) medication therapy at discharge, Kimberly D. Miller (P119D)
Board 120 Effect of formulary versus non-formulary medications on the rate of adverse drug events, Jared Cash, Jared Olson, Mark MacKay (P120D)
Board 121 Effective utilization of a failure modes and effects analysis (FMEA) to avoid anticipated patient safety issues with the implementation of insulin pens to a device naive institution, Leonardo R. A. Zoppa, Samia Fawzi, Marie Van De Veire, Marilyn Creamer, Vivian Steinmetz (P121D)
Board 122 Effects of implementing electronic nursing documentation on heparin dosing in a community hospital, Dennis B. Sharpe, Greg Teale, Charles Hayes, Erin Hohman (P122D)
Board 123 Enhancing the culture of safety: implementing a six sigma approach to improve compliance of intelligent infusion device technology at a multi-hospital system, Jane Dateshidze, Deborah A. Christopher (P123D)
Board 124 Evaluation of severe potentially preventable adverse drug reactions, Susie Shin, Stephanie Seyse, MaryAnne Dannenhoffer, Victor Kolade (P124D)
Board 125 Impact of second generation antipsychotics medication utilization evaluation in a veteran population: monitoring of weight, glucose, and lipids, Ni-Chi Wu, Sylvain DeLisle, Terri Hahn (P125D)
Board 126 Implementation of a pharmacy-driven anticoagulation patient education program at a 215-bed, non-teaching community hospital, Michael E. Collins, Misty Boachie (P126D)
Board 127 Improving the reporting of all adverse drug events: initiatives from the Department of Veterans Affairs Pharmacy Benefits Management web-based adverse drug events surveillance reporting system model, Vaiyapuri Subramaniam, Thomas Emmendorfer (P127D)
Board 128 Latent opportunities for errors in medication orders in four Canadian Health Authorities, Neil J. MacKinnon, Rumi Pattar, Tiffany Nguyen (P128E)
Board 129 Major hemorrhagic events in severe renal dysfunction: therapeutic reduced dose enoxaparin compared to continuous unfractionated heparin, Kimberly Garnett (P129E)
Board 130 Medication reconciliation: a process improvement initiative using third party adjudicated prescription information, Richa Airee, Jack Adams, Michele Durda, Alicia Pettis, Jennifer Key (P130D)
Board 131 Optimizing patient safety through pharmacy review of contrast agent orders, Evans T. Prieston, Jennifer R. Lindsey, David Grant (P131D)
Board 132 Qualitative and quantitative analysis of cytotoxic drugs in hospital-prepared infusions, Catherine Devys, Benedicte Lelievre, Mikael Daouphars, Florence Basuyau, Pierre Leynia de la Jarrige (P132D)
Board 133 Reduction in meperidine use in a community hospital without the need for formulary revision, David J. Lee (P133D)
Board 134 Role of failure modes and effects analysis (FMEA) in error prevention in a large, tertiary care medical center, Jennifer L. Brandt, Kimberly Krakowski, Joseph Barbaccia, Ann Marie Madden, Katherine Geiser (P134D)
Board 135 Standardizing adverse drug event reporting in a multi-hospital system, Richard H. Ensign, Jan Orton, Alejandra Bradshaw, Jefrey Huntington, Tina Aramaki (P135D)
Board 136 Strategies to reduce errors with insulin, Susan Kornblit, Radhika Pisupati, Mitch Sobel, Michael Cairoli (P136D)
Board 137 Surgical care improvement project (SCIP) results improved with pharmacist interventions, Yen N. Pham, Patricia A. Montgomery (P137D)
Board 138 Utilization of electronic technology to alert multiple disciplines of sound alike/look alike drugs (SALADs), Karen Korch Black, Fred Soetje, Chris Gallagher, Daphen Shum, Jeff Franklin (P138D)
Board 139 Utilizing computer systems to insure a safe medication bar-coding system, David L. Girouard, James Archambault, Aneta Grauer, Brian McDonald (P139D)
Board 140 Utilizing the ISMP quarterly action agenda and alerts to optimize medication safety, Christian Hartman, Hanh Chu, Roy Guharoy (P140D)
General Clinical Practice
Board 186 Evaluating microbial growth and stability of clopidogrel in three extemporaneously prepared oral liquid preparations, Weeranuj Yamreudeewong, Eric K. Dolence, Glaucia M. Teixeira (P186E)
Categories - Tuesday, 2:00 PM – 4:30 PM
Cateogries: Drug Information, General Clinical Practice, Infectious Diseases, Oncology, Operating Room Pharmacy, Outcomes Research, Pediatrics, Pharmacoeconomics, Pharmacokinetics, Pharmacy Technicians, Practice Research
Quality Assurance / Medication-Use Safety
Board 113 An assessment of a pharmacy-based enhancement to the hospital medication reconciliation process, Lucy Gizzi, Douglas Slain, Justin Hare, Renee Sager, Frank Briggs III (P113E)
Drug Information
Board 141 Bridging the drug safety information gap to enable consumers to take a more active role in their healthcare, Rose C. Plummer, Elisa Cascade (P141D)
Board 142 Characterization of drug information requests submitted for a televised news segment, Kristina E. Ward (P142D)
Board 143 Comparison of drug information databases, Amy Sutton Peak, Iftekhar Kalsekar, Sabrina Hopkins, Rebecca Lambert (P143E)
Board 144 Number and impact of published scholarly works by pharmacy practice faculty at US schools/colleges of pharmacy (2004-06), Lauren Schlesselman, C. Michael White, Craig Coleman (P144D)
Board 145 Pediatric dosing and safety content in drug information references available on personal digital assistants, Hyla H. Polen, Sandra Benavides, Chilla E. Goncz, Kevin A. Clauson (P145D)
Board 146 Psychogenic polydipsia and hyponatremia in a patient treated with desmopressin in a Joint Commission accredited facility, Julie M. Alizio (P146D)
Board 147 Uniform resource locator (URL) decay in an open access biomedical journal, Hyla H. Polen, Kevin A. Clauson, Shine A. Joseph (P147D)
Board 148 Acute CNS demyelinating disorder and hepatosplenic t-cell lymphoma associated with infliximab: mounting evidence for pharmacovigilance in the treatment of inflammatory bowel disease in pediatric patients, David N. Berkowitz (P148D)
Board 149 Annual analysis of anesthesia costs and appropriate use in a women's specialty hospital, Cindy Nettle, John Bridges, Eve C. Elias (P149D)
Board 150 Assessing compliance with the 2004 consensus guidelines of the American College of Chest Physician (ACCP) regarding the administration of vitamin K, Lisa Wagoner (P150D)
Board 151 Assessing institutional anticoagulation safety, Ryan Williams, Terry Baumann (P151D)
Board 152 Bad medicine or real medicine? The use of low-dose dopamine in an intensive care unit (ICU), Laura Lombera, Mikel Castaño, Unai Gonzalez, Saioa Sautua, Maria Puy Figuero (P152E)
Board 153 Benefits of a thiamine protocol for prophylaxis of Wernicke's encephalopathy in hospitalized patients, Chelsea O. Church, Erin D. Callen, Ben Welch (P153D)
Board 154 Characterization of intravenous levetiracetam use at a large teaching institution, Lauren M. Hynicka, Teresa Potter, Evren Burakgazi (P154D)
Board 155 Combination therapy with an angiotensin II receptor blocker (ARB) and angiotensin-converting enzyme inhibitor (ACE-I) in patients treated in a county hospital, Uche Anadu Ndefo, Andrea Henry, Kimberly Williams, Latoya Holley (P155D)
Board 156 Evaluation of a computerized physician order entry (CPOE) weight-based unfractionated heparin (UFH) protocol at Beth Israel Deaconess Medical Center (BIDMC): a focus on patient safety, Adam B. Woolley, Adam B. Woolley, Snehal H. Bhatt, Katherine Cunningham (P156D)
Board 157 Evaluation of an automatic interchange program of levalbuterol to albuterol in a community medical center, Jennifer Ng, Stacy Simon, Gretchen Hamm, Mary Manning (P157D)
Board 158 Evaluation of the utilization of tumor necrosis factor blockers in a county hospital system, Uche Anadu Ndefo, Angie Maxwell, Jacqueline Milton-Brown (P158D)
Board 159 Evaluation of vitamin K in an academic institution, Jessica Kay, Radhika Pisupati (P159D)
Board 160 Formulary guideline compliance for prescribing duloxetine in a county hospital system, Uche Anadu Ndefo, Dwayne Moore, Kimberly Williams (P160D)
Board 161 Medication adherence and the prescribing of generic or branded drug therapies, Becky A. Briesacher, Susan Andrade, Hassan Fouayzi, K. Arnold Chan (P161D)
Board 162 Medication use evaluation of conversion to darbepoetin in a county health care system outpatient hemodialysis clinic, Catherine McDaniel, Dianna Borowski-Wright (P162D)
Board 163 Multi-site medication use evaluation of atypical antipsychotics: results from a clinical pharmacy collaborative, Kerry L. Mello, Mark Curtis, Michele Danish (P163D)
Board 164 Patient safety initiative identified through an amiodarone use evaluation, Rodney Brumbelow (P164D)
Board 165 Phosphate solutions used for bowel preparation prior to a colonoscopy, Brian D. Sherman (P165D)
Board 166 Practice of deep venous thrombosis prophylaxis among inpatients in Lebanon: the renal dysfunction population, Abeer A. Zeitoun, Hani I. Dimasi, Dania Y. El-Kari, Marwan G. Akel (P166E)
Board 167 Retrospective analysis of esomeprazole use and adherence to established or approved prescribing guidelines in hospitalized patients, Uche Anadu Ndefo, Goldina Erowele, Dabelema Batubo (P167D)
Board 168 Role of drug use evaluations in action planning for National Patient Safety Goal 3E, Jennifer L. Brandt, Joseph Barbaccia, Hyon Kang (P168D)
Board 169 Usage and pharmacoeconomic analysis of the erythropoiesis-stimulating agents at a community hospital, David Damaske, Traci K. Thompson (P169D)
Board 170 Use evaluation of the erythropoiesis stimulating agents, epoetin alfa and darbepoetin alfa, in adult inpatients with anemia, Christopher R. Ensor, LeighAnne Hylton-Gravatt, Denise Kockler (P170D)
Board 171 Use of DVT prophylaxis in hospitalized cancer patients in a Lebanese hospital, Marwan Sheikh-Taha, Zeina Awar (P171E)
Board 172 Use of long acting risperidone injection (LAIRI) in an acute psychiatric hospitalization unit, Miren Ercilla, Ainhoa Asensio, Alvaro Aguirre, Maria Jose Arrizabalaga, Carmen Ripa (P172E)
Board 173 Use of midodrine in renal transplant patients, Estibaliz Perez, Ainara Campino, Begoña San Jose, Mikel Castaño, Francisco Javier Gonzalez (P173D)
Board 174 Valproic acid and carbapenem antibiotics: evaluation of a profound drug interaction, Larry K. Golightly, Jennifer K. Tobin, Michael A. Jones (P174D)
Board 175 Allopurinol hypersensitivity syndrome, Brad Hein (P175D
Board 176 Assessment of conversion from epoetin alfa to darbepoetin alfa in hospitalized hemodialysis patients, Clint D. Shadinger, Maria E. Taylor (P176E)
Board 177 Clinical and economic burden of atherosclerosis in clinical practice, Robert L. Ohsfeldt, Sanjay K. Gandhi, Kathleen M. Fox, Michael F. Bullano (P177D)
Board 178 Clinical and economic impact of interventions by a pharmacist on antibiotic use on surgical wards in a German hospital, Alexandra Weber, Eva Grill, Christian Schneider, Cornelia Vetter-Kerkhoff, Karl-Walter Jauch (P178E)
Board 179 Creation of a centralized pharmacist run international travel clinic: two years later, Teri L. Ogg, Jodi L. Longueil, Molly S. Stenzel, Niki L. Vogt (P179D)
Board 180 Cutting edge pharmaceutical care in the emergency departments – current practice across academic medical centers, Roy Guharoy, Steven Rough, Mike Fotis, Nora Flint, Katleen Wyatt (P180D)
Board 181 Deep vein thrombosis (DVT) risk assessment and outcomes in patients admitted to an internal medicine service, Brad Hein, Beth Frede, Erica Smith (P181D)
Board 182 Development of a pharmacist review process for contrast orders, Glenn Wysock, Jovino O. Hernandez (P182D)
Board 183 Development of a pharmacy rounding service in a community hospital, James B. Vander Linde, Shajal Patel, Christopher Kiser, Daniel Sypula (P183D)
Board 184 Early monitoring of liver function with the use of methimazole; the time has come, Emily L. Sexson, Tammy L. Burns, Andjela T. Drincic, Mark A. Malesker (P184D)
Board 185 Establishing a university based "Teaching New Teachers" program, Steve Fuller, Ann Marie Nye, Bob Cisneros, Jennifer Smith, Connie Barnes, (P185D)
General Clinical Practice
Board 187 Evaluating the incidence of heparin-induced thrombocytopenia as a complication of unfractionated heparin or low molecular weight heparin in the treatment of hospitalized patients in a community based hospital, Frances Anna Ordieres, Mercedes Frias, Aphinya Pathumsaengthong (P187D)
Board 188 Evaluation of the management of patients with heparin-induced thrombocytopenia at a university hospital, Stephanie H. Carroll, Timothy Aaron Jones, Marisa Marques (P188E)
Board 189 Impact of an emergency department clinical pharmacist in an urban, tertiary care, level II trauma center, Jessica Kay, Radhika Pisupati, William Gluckman, Mitch Sobel (P189D)
Board 190 Impact of clinical pharmacist-hospitalist collaboration in improving glycemic control at a community hospital, Joyce Lee, Tomas Villanueva, Radhan Gopalani, Heidi Clarke, Jennifer Steinberg (P190D)
Board 191 Long term impact of a workshop-based continuing education program on diabetes training for pharmacists, Jennifer Goldman-Levine, David M. Schnee, Matthew Silva (P191D)
Board 192 Optimizing the use of proton pump inhibitors at a community teaching hospital, Agnes Zajac (P192D)
Board 193 Provision of a pharmacist independent prescriber on the daily consultant admission round in a UK acute hospital, Roger W. Baker, Arthur Ogunko (P193D)
Board 194 Rhabdomyolysis with acute renal failure due to a simvastatin-ketoconazole drug interaction, Nancy Toedter Williams (P194D)
Board 195 Seamless care - admission and discharge management in a German university hospital, Anita Kellermann, Jakob Thurner, Stefanie Schuldt, Rudolf Bernard (P195D)
Board 196 Use of a warfarin monitoring card to achieve compliance with National Patient Safety Goal 3E, Kasey Johnson, Betsy Carlisle (P196D)
Infectious Diseases
Board 197 Assessment of a vancomycin monitoring program, Jessica Space, Aaron Jones (P197D)
Board 198 Decreasing respiratory fluoroquinolone use at a large tertiary care hospital, Keith S. Kaye, Michelle Sharpe, Deverick Anderson, Elizabeth Dodds Ashley (P198D)
Board 199 Fluoroquinolone formulary conversion in a large non-profit health system, Annette M. Karageanes, Larry J. Koesterer, Joel A. Hennenfent (P199D)
Board 200 Implementation of an antimicrobial stewardship service to control costs in a 389-bed non-teaching community hospital, Justin Hooper, Stephanie Hedges, Richard Yates (P200D)
Board 201 Safety analysis of cefepime in comparison to piperacillin/tazobactam at a university hospital, Kelly McKee, Carrie Cannella, Casey Williams (P201D)
Board 202 Utilization trending of resistant gram positive antibiotics in 38 hospitals (2004 - 2008), Kristi M. Kuper, Steve Lundquist, Leny Lee, Alisa Goetz (P202D)
Oncology
Board 203 Choice of antiemetic treatment: comparison of American Society of Clinical Oncology guidelines and European hospital clinical practice, César Salort, Susana Redondo, Rosa Garriga, Albert Planas, Ramón Pla (P203D)
Board 204 Compassionate use of bevacizumab for refractory neuroblastome, Maria Angeles Gil, Unai Gonzalez, Estibaliz Chavarri, Beatriz Sordo, Monike De Miguel (P204D)
Board 205 Evaluation of extended dosing intervals versus weekly dosing of darbepoetin alfa (DA): a phase 2 study in cancer patients (pts) with chemotherapy-induced anemia (CIA), Timothy Rearden, Lee Schwartzberg, Barry Mirtsching, Amy Inamoto, Tom Lillie (P205E)
Board 206 Evaluation of rituximab administration, Mika Kessans, Patricia Corrigan, Mandy Gatesman (P206D)
Board 207 Impact of chemotherapy induced hematotoxicity on blood component use and associated costs in NSCLC and lymphoma patients in Germany, Bernadette Paessens, Karin Berger, Angela Ihbe-Heffinger, Rudolf Bernard, Wolfgang Schramm (P207E)
Board 208 Impact of reimbursement changes for Erythropoiesis-Stimulating Agents (ESAs) on hospital transfusion trends in patients with cancer: an administrative data comparison between 2006 and 2007, Lynn M. Jurss, Chris Craver, Robert Nordyke (P208D)
Board 209 Improved high-performance liquid chromatographic UV detection of paclitaxel in patient’s plasma using a semi-micro bore C18 column, Manabu Suno, Katsutoshi Tahara, Jo Yamamoto, Shinya Iida, Kazuo Matsubara (P209E)
Board 210 Improving chemotherapy turn around time to the adult and pediatric outpatient oncology clinics as well as the adult and pediatric inpatients serviced by a single inpatient pharmacy using the Six Sigma methodology., Rebekah L. Kramer, Phillip J. Nelson (P210D)
Board 211 Infectious complications in patients undergoing intensification chemotherapy, Laura Lombera, Beatriz Baza, Saioa Sautua, Francisco Javier Gonzalez, Estibaliz Perez (P211E)
Board 212 Understanding colony-stimulating factor use and febrile neutropenia hospitalizations among oncology patients receiving chemotherapy treatment in US health-system outpatient clinics: opportunity for pharmacist intervention to improve clinical care and outc, Preetaman K. Wadhwa, Sharon S. Paik (P212D)
Board 213 Use of iron in cancer patients receiving erythropoiesis stimulating agents, Ashley Richards, Aimee Faso, Judy Ashe (P213D)
Operating Room Pharmacy
Board 214 Development and implementation of perioperative clinical pharmacy services at an academic medical center, Sara H. Cooper, Abbie C. Williamson (P214D)
Board 215 The comparative study of cost effectiveness of 5HT3 antagonist for the prevention of postoperative nausea and vomiting, Frank Aroh, Alexandria Bastien (P215E)
Board 216 The impact of pharmacy & anesthesiology collaborative practice on inhaled anesthetics, Frank Aroh, Robert Lagasse, Frank Sosnowski (P216D)
Board 217 Characterization of chronic kidney disease (CKD) and end-stage renal disease (ESRD) patient length of stay (LOS) in a managed care organization (MCO), Matthew Gitlin, Gregory Daniel, Donald Brophy, Tracy J. Mayne (P217D)
Outcomes Research
Board 218 Cost-efficacy analysis of anti-tumor necrosis factor therapy in the treatment of rheumatoid arthritis using radiologic outcomes, Boxiong Tang, Heidi Waters, R. Scott McKenzie, Catherine T. Piech (P218E)
Board 219 Heart disease risk knowledge among SHIELD respondents with dyslipidemia, Sandra J. Lewis, Kathleen M. Fox, Michael F. Bullano, Susan Grandy (P219D)
Board 220 Impact of Canadian drug policies on economic, clinical, and humanistic outcomes – a systematic review, Neil J. MacKinnon, Alena Morrison, Nicole Hartnell (P220E)
Board 221 Long-term outcomes after stent implantation in acute coronary syndrome patients: clinical consequences of suboptimal clopidogrel therapy, Karina Berenson, Daniel Wiederkehr, Michelle R. Krukas, Dinara Makenbaeva, Essy Mozaffari (P221E)
Board 222 Management of anemia in end stage renal disease patients in the U.S., Diane L. Frankenfield, Curtis A. Johnson (P222D)
Board 223 Outcomes from enfuvirtide use in a large community based HIV clinic, Teddy T. Zerai, Roberto A. Andrade, Thomas P. Giordano, Cyril V. Abobo, Denisse Martinez (P223D)
Board 224 The imperative for pharmacists to evaluate the impact on clinical decision making of a change in tacrolimus immunoassay, Teresa M. Cavanaugh, Jill Martin Boone, Valerie Culp, Nicholas Parrish, Steven Rudich (P224E)
Board 225 Time to goal blood pressure and clinical inertia among hypertensive patients initiating therapy, Joseph Biskupiak, Richard Baney, Jaewhan Kim, Feride Frech-Tamas (P225E)
Board 226 Treatment continuation and discontinuation patterns, resource utilization and costs among patients with epilepsy, Stephen S. Johnston, Laurie Costa, Emily Durden, David Biondi, Jamie Forlenza (P226D)
Pediatrics
Board 227 Amoxicillin/clavulanate vs. guideline recommended second-line cephalosporins for acute otitis media: a meta-analysis, Joshua David Courter, Jennifer Ellis Girotto (P227E)
Board 228 Comparison of medication order entry error rates in a neonatal intensive care unit versus an adult intensive care unit in a predominantly adult hospital, Sara Ridges, Franklin Huggins (P228E)
Board 229 Evaluation of the impact of palivizumab therapy management program in a community institution, Rosebel Nesiama Efejuku, Ligy John, Alphonsus U. Okpara, Ryan Roux (P229D)
Board 230 Functional diagnosis of cystic fibrosis, Martin J. Hug, Tatjana Von Massenbach, Peter Greiner, Matthias Kopp (P230E)
Board 231 Implementation of a standardized dosing protocol in the neonatal intensive care unit, Emily C. Shunk, Dave R. Nash, Christelle E. Polaski, Cara K. Olsen (P231D)
Board 232 Is single dose intramuscular ceftriaxone equivalent to standard oral first line treatments for children with acute otitis media? a meta-analysis, Shannon E. Dugan, Joshua David Courter, Jennifer Ellis Girotto (P232E)
Board 233 Measurement of the financial impact of a multidisciplinary palivizumab (Synagis®) dosing program within a tertiary care teaching facility, Jennifer Costello, Mary Sellar, Robert Adamson, Coleen Murphy, Timothy Yeh (P233D)
Board 234 Monitoring of an extended-interval aminoglycoside dosing regimen in neonates, Kathy Pham, Liana Mark, Jessica Gomez (P234D)
Board 235 Pediatric emergency pharmacy services: cost savings and clinical benefits, Jennifer Bradbury, Mark MacKay, Kevin Jones, Marc Holley (P235D)
Board 236 Pharmacist involvement with pediatric emergency response in a community hospital setting, Daniel Ryszka, Kristen Kusmierski, Cynthia Lackie, Andrea Rubino, James Fenner (P236D)
Board 237 Pharmacokinetics of single and multiple doses of pantoprazole delayed release granules for oral suspension in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD ), Mary K. Maguire, Sandra E. Sullivan, Dan L. Stewart, Brinda Tammara, Natalie Rath (P237E)
Board 238 Stability of extemporaneously prepared moxifloxacin oral suspensions, David J. Hutchinson, Cary E. Johnson, Kristin C. Klein (P238D)
Board 240 Treatment of mild to moderate dehydration with oral ondansetron in the pediatric emergency department at a children's hospital, Sonia T. Sosa, Anyzeila Diaz, Ligio Antonio Tavares, Martha Villabona (P240D)
Board 241 Vancomycin dosing in the neonatal intensive care population, JoLeigh A. Sutton, Kimberly Ross Wurst (P241D)
Pharmacoeconomics
Board 242 A cost effectiveness analysis of rimonabant versus sibutramine on metabolic outcomes in obese patients with type 2 diabetes mellitus, over a 1 year period: a third party perspective, Michelle Bennett, Cathy Au, Eric Ferro, Joseph Skellie, Melinda Martland (P242D)
Board 243 Cost effectiveness of daptomycin versus vancomycin in initial treatment success of patients with infective endocarditis: a hospital perspective, Jason Andree, Taner Tan, SaraBeth Hahn, Noah Farrington (P243D)
Board 244 Cost effectiveness of prasugrel versus clopidogrel in the prevention of non-fatal ischemic events in patients with acute coronary syndrome following percutaneous coronary intervention after twelve months from a third party perspective, Terence Khuu, Nathaniel Weidner, Adeolu Odewale, Rathasen Prom (P244D)
Board 245 Cost effectiveness of valsartan vs. losartan to delay nephropathy progression in patients with type 2 diabetes and hypertension, Hsing-Ting Yu, Zhimei Liu, Homa Dastani, Quan V. Doan, Suellen Curkendall (P245E)
Board 246 Cost effectiveness of zoledronic acid versus alendronate in preventing clinical fractures in postmenopausal women with an underlying risk over a three year period from a third party perspective, Stephanie N. Melillo, Ilia E. Antonino, Courtney E. Bellows, David A. Blaser, Jonathan Destasio (P246D)
Board 247 Cost-effectiveness analysis of dexmedetomidine versus midazolam in adult cardiac surgical patients requiring mechanical ventilation to reduce time of intubation, decrease administration of opioid analgesics, and reduce length of intensive care unit (ICU), Christopher R. Shaw, Henri L. Valois, III, Cheryl A. Panciocco, Evan B. Taylor, Janeen M. Poirier (P247D)
Board 248 Cost-effectiveness analysis of five years of treatment with either raloxifene 60mg or tamoxifen 20mg for the primary prevention of any type of breast cancer in high risk women at least 35 years of age: a third party payer perspective, Matthew Benoit, Kristen Bunnell, Katie Hall, Roshni Patel, Heather Torbic (P248D)
Board 249 Cost-effectiveness analysis of voriconazole versus caspofungin as empiric antifungal therapy for febrile neutropenic patients, Natasha Patel, Nathan H. Hartwell, Lisa M. Goodman, Kevin V. Lai (P249D)
Board 250 Cost-effectiveness of varenicline vs. nicotine patch for smoking cessation in adults from the managed-care perspective over a 12 month period, Basma Sadaka, Leandra Duva, Jessica Russo, Jenni Stein, Jessica Zou (P250D)
Board 251 Costs associated with gastrointestinal adverse events after opioid treatment in the outpatient setting from the payor perspective, Joris Diels, W. J. Kwong, Shane Kavanagh (P251D)
Board 252 Cost-utility analysis of lamotrigine monotherapy compared to carbamazepine monotherapy for the treatment of adult partial seizures from the managed care perspective over a two-year period, Carol Kycia, Onik Ivanian, Robyn Seely, Sampson Tona, Michel Tremblay (P252D)
Board 253 Effects of carbamazepine versus gabapentin in patients with newly diagnosed, treatment naive partial epilepsy, Patrick Galuski, Monique Larue, Ashley Richardson, Wesley Day, Kevin Sullivan (P253D)
Board 254 Impact of education on immunization on the willingness to pay for pharmacist based immunization services among hispanics, Simon Leung, Oluyinka Agboola (P254E)
Board 255 Oral topiramate 300mg vs. oral naltrexone 50mg for the long-term treatment of alcohol dependence in adults over a 12-week period: a cost-effectiveness analysis, Solange Mason, Anthony Dargush, Caleb Dodd, Amanda Sesto, Justin Tesch (P255D)
Board 256 Primary prevention of febrile neutropenia in high-risk breast cancer patients over four chemotherapy cycles with either pegfilgrastim, clinician-administered filgrastim or patient-administered filgrastim from a third party payer perspective: a dual cost-e, Caitlin M. Kennelly, Erica Punko, Michael Rio, Megan LoVullo, Allison Rappoport (P256D)
Board 257 Resource use and costs associated with routine management of chemotherapy associated toxicity in German hospitals, Bernadette Paessens, Christoph von Schilling, Rudolf Bernard, Christian Peschel, Angela Ihbe-Heffinger (P257E)
Board 258 The cost effectiveness and cost utility evaluation of oral sapropterin versus conventional PKU diet measuring reductions in phenylalanine levels in patients with PKU from a third party perspective over 18 months, Daniela DeSantis, Allison Chang, Priyanka Patel, Dharmesh Joshi, Kerri Sawicki (P258D)
Board 259 The cost-effectiveness and cost-utility of adalimumab versus methotrexate in the treatment of moderate to severe chronic plaque psoriasis in adult patients from a third-party payer perspective over a 16-week period., Devang R. Nagrecha, Diana Chandler, Jason Exter, Doug Boyle, Michele Vinci (P259D)
Board 260 The cost-effectiveness of caspofungin vs. micafungin, Yana Kogan, Amy Devoid, Mary Burke, Elizabeth Mayo (P260D)
Pharmacokinetics
Board 261 A study of the population pharmacokinetic characteristics of trospium chloride 60 mg once-daily extended release capsules in patients with overactive bladder and healthy subjects, Mark Harnett, James Shipley, Laura MacLean, Ute Schwiderski, Bobby Sandage (P261E)
Board 262 Impact of strong inhibitors or inducers of CYP3A on the pharmacokinetics of casopitant, a novel NK-1 receptor antagonist, Lyndon C. Kirby, Brendan M. Johnson, Laurel M. Adams, Ke Zhang, Shelby D. Gainer (P262D)
Board 263 Pharmacy monitoring of vancomycin accumulation in a patient following total hip replacement, James K. Williamson, Ginger R. Bain (P263E)
Pharmacy Technicians
Board 264 Development of pharmacy technician training program to establish standardized expectations, improve patient safety, and retention of motivated pharmacy technicians, Janet Schretlen-Doherty, Cherryl Peterson, Donavan Engleman, Sergio Salinas (P264D)
Board 265 Innovative solution to technician manpower shortage, Heather Benjamin-Alexis, Ann Breakenridge (P265D)
Board 266 Medication reconciliation: a pharmacy technician based admissions process, Jessica J. Montour (P266D)
Board 267 Technician check technician: a pilot study of technicians checking unit dose cart filling at Arkansas Children's Hospital, Garry Enderlin, Michael Houlihan, Anthony Vertino (P267D)
Board 268 Utilization of clinical pharmacy technicians for medication reconcilliation on admission to a VA medical ward, Lezlie Anne Cohn-Oswald, Steven Moser (P268D)
Practice Research
Board 269 Can a student-run safety net clinic with limited funds meet the national standards of care for diabetes?, Shannon Schultz, Donald Klepser, Kristen Cook (P269D)
Board 270 Community perception of value offered by clinical pharmacotherapy management services, Jonathan D. Hoffman (P270D)
Board 271 Errors and violations in community pharmacies: a focus group study, Darren M. Ashcroft, Dianne Parker, Peter Noyce (P271D)
Board 272 Evaluating a rate increase in C. difficile infection in a community hospital, Stephanie Traher-Hebert, Zach Finney, Ferena Salek, Jon Glover (P272D)
Board 273 Impact of a pharmacy-driven empiric antibiotic guideline implementation on physician prescribing habits in a community ospital setting, Melody L. Berg, Jacob P. Gettig, Kelly V. Hunnius (P273D)
Board 274 Impact of an emergency department clinical pharmacist on pneumonia care, Francia N. Kellner, Christopher F. Freer, Chris Ruhren (P274D)
Board 275 Impact of pharmacy discharge medication reconciliation during medication counseling, Huzefa H. Master, Nina Huang (P275D)
Board 276 Pharmacy education and practice in twelve Middle Eastern countries, Maguy S. El Hajj, Kerry Wilbur, Husam Younes, Nadir Kheir, Manal B. Al-Zaidan (P276D)
Board 277 Physicians' comfort, expectations and experience with pharmacists at Hamad Medical Corporation (HMC) in Qatar, Manal Zaidan, Rajvir Singh, Mayyada Wazaify, Linda Tahaineh (P277E)
Board 278 Rate of obesity in U.S. ambulatory patients with diabetes mellitus: a national assessment of office-based physician visits, Cristina A.K. DuVall, Joshua J. Neumiller, David A. Sclar, Linda Robison, Tracy L. Skaer (P278D)
Board 279 Understanding safety climate in community pharmacies: cross-sectional study in the UK, Darren M. Ashcroft, Dianne Parker (P279D)